BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36162129)

  • 1. Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed Tumors.
    Slaats J; Wagena E; Smits D; Berends AA; Peters E; Bakker GJ; van Erp M; Weigelin B; Adema GJ; Friedl P
    Cancer Immunol Res; 2022 Dec; 10(12):1462-1474. PubMed ID: 36162129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth.
    Mediavilla-Varela M; Luddy K; Noyes D; Khalil FK; Neuger AM; Soliman H; Antonia SJ
    Cancer Biol Ther; 2013 Sep; 14(9):860-8. PubMed ID: 23917542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.
    Cekic C; Day YJ; Sag D; Linden J
    Cancer Res; 2014 Dec; 74(24):7250-9. PubMed ID: 25377469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro induction of T cells that are resistant to A2 adenosine receptor-mediated immunosuppression.
    Ohta A; Kjaergaard J; Sharma S; Mohsin M; Goel N; Madasu M; Fradkov E; Ohta A; Sitkovsky M
    Br J Pharmacol; 2009 Jan; 156(2):297-306. PubMed ID: 19076726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A
    Kjaergaard J; Hatfield S; Jones G; Ohta A; Sitkovsky M
    J Immunol; 2018 Jul; 201(2):782-791. PubMed ID: 29802128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Screening of Cytotoxic T-cell Effector Function Reveals the Role of CRAC Channels in Regulating Lethal Hit Delivery.
    Slaats J; Dieteren CE; Wagena E; Wolf L; Raaijmakers TK; van der Laak JA; Figdor CG; Weigelin B; Friedl P
    Cancer Immunol Res; 2021 Aug; 9(8):926-938. PubMed ID: 34226201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment.
    Mediavilla-Varela M; Castro J; Chiappori A; Noyes D; Hernandez DC; Allard B; Stagg J; Antonia SJ
    Neoplasia; 2017 Jul; 19(7):530-536. PubMed ID: 28582704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine A2A receptors intrinsically regulate CD8+ T cells in the tumor microenvironment.
    Cekic C; Linden J
    Cancer Res; 2014 Dec; 74(24):7239-49. PubMed ID: 25341542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia.
    Sitkovsky MV; Kjaergaard J; Lukashev D; Ohta A
    Clin Cancer Res; 2008 Oct; 14(19):5947-52. PubMed ID: 18829471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8
    Mastelic-Gavillet B; Navarro Rodrigo B; Décombaz L; Wang H; Ercolano G; Ahmed R; Lozano LE; Ianaro A; Derré L; Valerio M; Tawadros T; Jichlinski P; Nguyen-Ngoc T; Speiser DE; Verdeil G; Gestermann N; Dormond O; Kandalaft L; Coukos G; Jandus C; Ménétrier-Caux C; Caux C; Ho PC; Romero P; Harari A; Vigano S
    J Immunother Cancer; 2019 Oct; 7(1):257. PubMed ID: 31601268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase A type I signaling.
    Raskovalova T; Lokshin A; Huang X; Su Y; Mandic M; Zarour HM; Jackson EK; Gorelik E
    Cancer Res; 2007 Jun; 67(12):5949-56. PubMed ID: 17575165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Microtubule-Network Rescues CTL Killing Efficiency in Dense 3D Matrices.
    Zhao R; Zhou X; Khan ES; Alansary D; Friedmann KS; Yang W; Schwarz EC; Del Campo A; Hoth M; Qu B
    Front Immunol; 2021; 12():729820. PubMed ID: 34484240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors.
    Beavis PA; Divisekera U; Paget C; Chow MT; John LB; Devaud C; Dwyer K; Stagg J; Smyth MJ; Darcy PK
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14711-6. PubMed ID: 23964122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human telomerase reverse transcriptase-transduced human cytotoxic T cells suppress the growth of human melanoma in immunodeficient mice.
    Verra NC; Jorritsma A; Weijer K; Ruizendaal JJ; Voordouw A; Weder P; Hooijberg E; Schumacher TN; Haanen JB; Spits H; Luiten RM
    Cancer Res; 2004 Mar; 64(6):2153-61. PubMed ID: 15026357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Pyridinone Derivatives as Potent, Selective, and Orally Bioavailable Adenosine A
    Zhu C; Ze S; Zhou R; Yang X; Wang H; Chai X; Fang M; Liu M; Wang Y; Lu W; Xie Q
    J Med Chem; 2023 Apr; 66(7):4734-4754. PubMed ID: 36951370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy.
    Giuffrida L; Sek K; Henderson MA; Lai J; Chen AXY; Meyran D; Todd KL; Petley EV; Mardiana S; Mølck C; Stewart GD; Solomon BJ; Parish IA; Neeson PJ; Harrison SJ; Kats LM; House IG; Darcy PK; Beavis PA
    Nat Commun; 2021 May; 12(1):3236. PubMed ID: 34050151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical-Grade Human Multipotent Adult Progenitor Cells Block CD8+ Cytotoxic T Lymphocytes.
    Plessers J; Dekimpe E; Van Woensel M; Roobrouck VD; Bullens DM; Pinxteren J; Verfaillie CM; Van Gool SW
    Stem Cells Transl Med; 2016 Dec; 5(12):1607-1619. PubMed ID: 27465071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting adenosine A
    Congreve M; Brown GA; Borodovsky A; Lamb ML
    Expert Opin Drug Discov; 2018 Nov; 13(11):997-1003. PubMed ID: 30336706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms and biological significance of CTL avidity.
    Snyder JT; Alexander-Miller MA; Berzofskyl JA; Belyakov IM
    Curr HIV Res; 2003 Jul; 1(3):287-94. PubMed ID: 15046253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.